FDA inspection
Irenda Corporation: FDA inspection ending May 19, 2006
FDA inspection 426653 · Official Action Indicated (OAI) · Los Angeles, CA
Key facts
| Inspection ID | 426653 |
|---|---|
| Firm | Irenda Corporation |
| FEI number | 2050154 |
| Address | 14131 Avalon Blvd |
| City | Los Angeles |
| State | CA |
| ZIP | 90061-2637 |
| Fiscal year | 2006 |
| Inspection end date | May 19, 2006 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data